Old Web
English
Sign In
Acemap
>
Paper
>
Evaluation of Shorter Infusion Times with Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis
Evaluation of Shorter Infusion Times with Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis
2019
Timothy Vollmer
Enrique Alvarez
Kavita V. Nair
Jeffrey A. Cohen
Aaron Boster
Ashish Pradhan
B Musch
Xiaoye Ma
Jinglan Pei
Ming Yang
Brandon P. Moss
Bianca Weinstock Guttman
Robert A. Bermel
Keywords:
Gastroenterology
Multiple sclerosis
Internal medicine
Ocrelizumab
Medicine
in patient
relapsing remitting
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]